email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1291 - 1305
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Innovent and HutchMed Report Positive Results from Combo CRC Therapy
$5.00
Available
Dingdang Health Raises $220 Million for Online-Offline Health Services
$5.00
Available
Innovent and IASO Report Positive Data on BCMA CAR-T Therapy
$5.00
Available
OriginCell Posts Positive Data from Trial of GPC3 CAR-T for HCC
$5.00
Available
Ascletis Approved to Start China Trials of FXR Agonist for Hepatitis B
$5.00
Available
Junshi Reports PD-1 Effective in Nasopharyngeal Carcinoma
$5.00
Available
MicuRx Approved for China Launch of Next-Gen Antibiotic
$5.00
Available
Shanghai Stemirna Lands $200 Million to Develop mRNA COVID Vaccine
$5.00
Available
IASO BIO to Start Trials of CAR-T in Leukemia Patients
$5.00
Available
Innovent Bio and Lilly Announce Third China Approval for PD-1
$5.00
Available
Phanes Therapeutics Raises $40 Million for mAb and Bi-specific Portfolio
$5.00
Available
Neurophth and Hopstem Partner to Develop Stem Cell Therapies for Eye Diseases
$5.00
Available
Zai In-licenses KRAS Inhibitor from Mirati in $338 Million Deal
$5.00
Available
Guangzhou-Israel Biomed Fund to Raise $300 Million
$5.00
Available
Innovent Announces $189 Million Agreement for TKI from Hangzhou Company
$5.00
Available